Novel Metabolic Disease Therapy

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20120053222A1
SERIAL NO

13145906

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention relates to the prevention and treatment of metabolic abnormalities characterized by abnormal glucose metabolism, including diabetes mellitus and new onset diabetes mellitus through the use of fibroblast activation protein (FAP) selective inhibitors.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
THE UNIVERSITY OF SYDNEYPARRAMATTA ROAD THE UNIVERSITY OF SYDNEY NEW SOUTH WALES CAMPERDOWN 2006
CENTENARY INSTITUTE OF CANCER MEDICINE AND CELL BIOLOGYMISSENDEN ROAD NEW SOUTH WALES CAMPERDOWN 2050

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Gorrell, Mark New South Wales, AU 1 43
Song, Sunmi New South Wales, AU 1 43
Wang, Xin New South Wales, AU 1487 14353

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation